Contents hide 1 Chronic Immune Thrombocytopenia (ITP) 2 Chronic Hepatitis C-associated Thrombocytopenia 3 Severe Aplastic Anemia 3.1 First-line therapy 3.2 Refractory SAA Eltrombopag is used to  treat thrombocytopenia (a low blood platelet count) in adults and children with chronic immune thrombocytopenic purpura that did not get better with other treatment. Chronic Immune Thrombocytopenia (ITP) Indicated in patients with insufficient response to corticosteroids, immunoglobulins, or splenectomy Use only in patients with ITP whose clinical condition increases bleeding risk Initial: 50 mg PO qDay Maintenance: Adjust dose to achieve and maintain platelet count (Plt) >50 x 10^9/L to reduce risk of bleeding; … Continue reading ELTROMDX 25 (Eltrombopag)